ABVC - ABVC BIOPHARMA, INC.
1.05
0.030 2.857%
Share volume: 79,189
Last Updated: 05-12-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$1.02
0.03
0.03%
Summary score
51%
Profitability
35%
Dept financing
42%
Liquidity
28%
Performance
75%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-17.69%
Return on sales
-25909.81%
Return on invested capital
0%
Total debt ratio
53.36%
Debt ratio change over timeo
0%
Current Ratio
0.7%
Quick Ratio
1.14%
Cash Position Ratio
0.17%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-9.7%
Return on sales
-6152.49%
Return on invested capital
0%
Total debt ratio
52.7%
Debt ratio change over timeo
0%
Current Ratio
0.42%
Quick Ratio
0.42%
Cash Position Ratio
0.06%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-14.7%
Return on sales
436.73%
Return on invested capital
0%
Total debt ratio
47.24%
Debt ratio change over time
0%
Current Ratio
0.41%
Quick Ratio
0%
Cash Position Ratio
0.11%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABVC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -17.69% | 4.74% | 3.19% | 0% |
| Return on sales | -25909.81% | 30.88% | 25.28% | 0% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 0% |
| Total debt ratio | 53.36% | 80.37% | 59.38% | 0% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 0% |
| Dept financing | 42% | 25% | 18% | 0% |
| Current Ratio | 0.42% | 1.44% | 1.09% | 0% |
| Quick Ratio | 0.42% | 1.12% | 0.84% | 0% |
| Cash Position Ratio | 0.06% | 0.16% | 0.44% | 0% |
| Liquididy | 48% | 53% | 69% | 0% |
| Short-term ratios | ABVC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -9.7% | 6.06% | 4.18% | 0% |
| Return on sales | -6152.49% | 39.61% | 26.91% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 52.7% | 80% | 59.26% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 41% | 25% | 19% | 0% |
| Current Ratio | 0.42% | 1.44% | 1.09% | 0% |
| Quick Ratio | 0.42% | 1.12% | 0.84% | 0% |
| Cash Position Ratio | 0.06% | 0.16% | 0.44% | 0% |
| Liquididy | 20% | 59% | 63% | 0% |